Members may individually decide whether to accept or donate red cells, white cells, plasma or platelets, while the position on whole blood remains unchanged
Jehovah’s Witnesses have made the use of red cells, white cells, plasma and platelets a matter of individual conscience, significantly widening the medical choices available to members. The decision does not lift the religion’s prohibition on whole-blood transfusions, but it changes a policy that has shaped treatment decisions in hospitals around the world.
A substantial change in the understanding of the doctrine
The Governing Body announced the adjustment on 18 September, extending individual choice to the four primary components derived from another person’s blood. Members may also decide whether to donate blood when its clearly stated purpose is to provide components or fractions for another patient.
The development, first highlighted in a World Religion News report, is the second significant revision of the Witnesses’ blood policy this year. In March, the organisation said members could decide whether to have their own blood collected, stored and returned to them during medical or surgical care.
Previously, fractions derived from blood components, including some proteins and clotting factors, could be accepted as a matter of conscience. The four primary components themselves were rejected. That distinction has now been removed.
In its updated explanation of the policy, the Governing Body says the Bible does not specifically address the products derived from blood and that congregations should neither become involved in individual decisions nor judge members for them.
The organisation continues to teach that blood is sacred, basing its position on biblical instructions to “abstain from blood”. Members are still instructed not to accept whole blood, donate blood for whole-blood transfusion or consume blood.
What changes at the hospital bedside
The practical implications may be extensive. Modern transfusion medicine commonly separates donated blood into components so that patients receive the product required for a particular condition. Red cells restore oxygen-carrying capacity, platelets help control bleeding, and plasma provides proteins involved in clotting. White-cell transfusions are less common and used in specialised circumstances.
A Witness patient may therefore now consider treatments that would previously have conflicted with the religion’s stated rules. That does not mean every member will accept them. Some may continue to reject every product derived from donated blood, while others may accept one component but decline another.
Hospitals should consequently avoid treating “Jehovah’s Witness” as a shorthand for automatic refusal of all blood components. Clinicians will need to ask each patient what they accept, explain the risks and alternatives, and document the decision precisely.
Existing advance directives may also require review. A form completed under the previous policy could record refusals that no longer reflect the patient’s wishes. The organisation says an updated medical directive will be issued and that members do not ordinarily need to disclose their choices beyond the healthcare agents named in that document.
Conscience must work in both directions
The human-rights principle is two-sided. A competent adult has the right to refuse treatment, including treatment that doctors believe is necessary to preserve life. The same person must also be free to accept an available treatment without pressure from relatives, religious representatives or medical professionals.
This balance is especially important in Europe. The European Court of Human Rights has emphasised that medical authorities must establish a patient’s genuine wishes when religious conviction and emergency treatment intersect. The European Times previously examined that principle through the Pindo Mulla blood-transfusion case in Spain.
The new policy’s promise of confidentiality may help members make decisions based on their own beliefs and medical circumstances. Its value, however, will depend on whether that privacy is respected in practice and whether information is communicated quickly in the languages used by the global membership.
The Governing Body has not withdrawn the theological basis of its position or offered a detailed public accounting of the earlier rule. It presents the revision as the result of prayerful consideration and a recognition that leaders should not impose requirements where Scripture is silent.
There are also practical questions about donation. National blood services generally determine how donated blood is processed and used, meaning that a donor’s request that it be reserved exclusively for components or fractions may not be administratively straightforward in every country.
The policy is therefore significant. It opens access to treatments that form a central part of contemporary transfusion medicine, but retains the whole-blood prohibition and leaves implementation to individual patients, clinicians and local healthcare systems.
The measure allow now every Witness patient to receives timely information, confidential counselling and a genuine opportunity to decide.
